MedPath

Assessment of ovarian reserve using serum AMH levels in patients after gynecologic surgery and chemotherapy for breast cancer

Not Applicable
Conditions
endometrioma
Registration Number
JPRN-UMIN000019369
Lead Sponsor
Obstetrics and Gynecology, Nagoya University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

possible ovarian cancer

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
serum AMH levels one month before treatment, and 1,12 months afer treatment
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath